The domain within your query sequence starts at position 1522 and ends at position 1809; the E-value for the ASD2 domain shown below is 8.9e-108.
EALAKEIVHQDKSLADILDPDSRMKTTMDLMEGLFPGDASVLMDSGAKRKALDITARRAG CEAKASDHKEAVSVLVNCPAYYSVSAAKAELLNKIKDMPEELQEEEGQEDVNEKKAELIG SLTHKLESLQEAKGSLLTDIKLNNALGEEVEALISELCKPNEFDKYKMFIGDLDKVVNLL LSLSGRLARVENVLRGLGEDASKEERSSLNEKRKVLAGQHEDARELKENLDRRERVVLDI LANYLSAEQLQDYQHFVKMKSTLLIEQRKLDDKIKLGQEQVRCLLESL
ASD2 |
![]() |
---|
PFAM accession number: | PF08687 |
---|---|
Interpro abstract (IPR014799): | The Shroom family is a small group of related proteins that are defined by sequence similarity and in most cases by some link to the actin cytoskeleton. The Shroom (Shrm) protein family is found only in animals. Proteins of this family are predicted to be utilised in multiple morphogenic and developmental processes across animal phyla to regulate cells shape or intracellular architecture in an actin and myosin-dependent manner [ (PUBMED:16684770) ]. The Shrm family consists of:
This protein family is based on the conservation of a specific arrangement of an N-terminal PDZ domain, a centrally positioned sequence motif termed ASD1 (Apx/Shrm Domain 1) and a C-terminal motif termed ASD2 [ (PUBMED:16684770) (PUBMED:17009331) (PUBMED:10589677) ]. Shrm2 and Shrm3 contain all three domains, while Shrm4 contains the PDZ and ASD2 domains, but lacks a discernible ASD1 element. To date, the ASD1 and ASD2 elements have only been found in Shrm-related proteins and do not appear in combination with other conserved domains. ASD1 is required for targeting actin, while ASD2 is capable of eliciting an actomyosin based constriction event [ (PUBMED:16684770) (PUBMED:17009331) ]. ASD2 is the most highly conserved sequence element shared by Shrm1, Shrm2, Shrm3, and Shrm4. It possesses a well conserved series of leucine residues that exhibit spacing consistent with that of a leucine zipper motif [ (PUBMED:16684770) ]. This entry represents the ASD2 motif of the Shroom proteins. |
This is a PFAM domain. For full annotation and more information, please see the PFAM entry ASD2